![Jennifer Riley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennifer Riley
Corporate Officer/Principal bij
AVALO THERAPEUTICS, INC.
Vermogen: 733 582 $ op 30-06-2026
Profiel
Jennifer Riley is the founder of Northbrook Consulting LLC, founded in 2014.
Ms. Riley is currently Chief Strategy Officer at Avalo Therapeutics, Inc., starting in 2025.
Formerly, Ms. Riley was Vice President-Program Leadership & Management at Biogen, Inc. Ms. Riley completed undergraduate studies at the University of California San Diego and graduate studies at Harvard Business School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-06-2026 | 39.696 ( 0,08% ) | 733 582 $ | 30-06-2026 |
Actieve functies van Jennifer Riley
| Bedrijven | Functie | Begin |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Corporate Officer/Principal | 01-01-2025 |
Eerdere bekende functies van Jennifer Riley
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | - |
Opleiding van Jennifer Riley
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
3
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
